Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13526
CALL
First Bancorp
FBP
$4.14B
| $11.2K | ﹤0.01% |
600
-1,800
| -75% | -$36.3K |
2024 Q2
2 quarters
|
|
|
YSG
13527
PUT
Yatsen Holding
YSG
$242M
| $11.1K | ﹤0.01% |
2,800
+2,600
| +1,300% | +$10.7K |
2020 Q4
16 quarters
|
|
|
ONL
13528
PUT
Orion Office REIT
ONL
$135M
| $11.1K | ﹤0.01% |
3,000
-3,200
| -52% | -$12.6K |
2022 Q4
8 quarters
|
|
13529
PUT
Eledon Pharmaceuticals
ELDN
$203M
| $11.1K | ﹤0.01% |
+2,700
| New | +$10.6K |
2024 Q4
0 quarters
|
|
|
EDVA
13530
Endovia Health Sciences, Inc.
EDVA
$1.15M
| $11.1K | ﹤0.01% |
+432
| New | +$14.3K |
2024 Q4
0 quarters
|
|
13531
CALL
Shore Bancshares
SHBI
$762M
| $11.1K | ﹤0.01% |
700
+500
| +250% | +$7.75K |
2024 Q3
1 quarter
|
|
13532
PUT
NCR Voyix
VYX
$944M
| $11.1K | ﹤0.01% |
800
-13,400
| -94% | -$186K |
2013 Q2
46 quarters
|
|
|
RGLS
13533
PUT
DELISTED
Regulus Therapeutics
RGLS
| $11.1K | ﹤0.01% |
7,000
-2,300
| -25% | -$3.53K |
2023 Q2
6 quarters
|
|
13534
PUT
Innospec
IOSP
$2.41B
| $11K | ﹤0.01% |
100
-1,100
| -92% | -$126K |
2024 Q3
1 quarter
|
|
13535
CALL
Acurx Pharmaceuticals
ACXP
$5.63M
| $11K | ﹤0.01% |
675
+215
| +47% | +$6.47K |
2023 Q4
4 quarters
|
|
13536
PUT
iShares MSCI Singapore ETF
EWS
$1.44B
| $10.9K | ﹤0.01% |
+500
| New | +$11.1K |
2024 Q4
0 quarters
|
|
13537
PUT
PDS Biotechnology
PDSB
$87M
| $10.9K | ﹤0.01% |
6,700
+600
| +10% | +$1.59K |
2021 Q2
14 quarters
|
|
13538
CALL
SCYNEXIS
SCYX
$50M
| $10.9K | ﹤0.01% |
1,125
-163
| -13% | -$1.69K |
2024 Q2
2 quarters
|
|
|
LLYX
13539
PUT
Defiance Daily Target 2x Long LLY ETF
LLYX
$42.5M
| $10.9K | ﹤0.01% |
+600
| New | +$13K |
2024 Q4
0 quarters
|
|
|
NINE
13540
PUT
DELISTED
Nine Energy Service
NINE
| $10.9K | ﹤0.01% |
9,700
+1,900
| +24% | +$2.24K |
2021 Q4
12 quarters
|
|
13541
Rekor Systems
REKR
$50.1M
| $10.9K | ﹤0.01% |
6,956
-662,263
| -99% | -$687K |
2022 Q1
11 quarters
|
|
|
IMMP
13542
CALL
Immutep
IMMP
$31.5M
| $10.8K | ﹤0.01% |
250
-180
| -42% | -$7.23K |
2022 Q4
8 quarters
|
|
13543
CALL
Caribou Biosciences
CRBU
$128M
| $10.8K | ﹤0.01% |
6,800
-36,000
| -84% | -$72.4K |
2021 Q4
12 quarters
|
|
13544
PUT
Research Frontiers
REFR
$25.4M
| $10.8K | ﹤0.01% |
+6,300
| New | +$12.3K |
2024 Q4
0 quarters
|
|
13545
CALL
Zedge
ZDGE
$46M
| $10.8K | ﹤0.01% |
4,000
+300
| +8% | +$873 |
2021 Q1
15 quarters
|
|
13546
PUT
Televisa
TV
$1.21B
| $10.8K | ﹤0.01% |
6,400
-2,200
| -26% | -$4.77K |
2024 Q3
1 quarter
|
|
|
SPNS
13547
PUT
DELISTED
Sapiens International
SPNS
| $10.7K | ﹤0.01% |
400
-600
| -60% | -$19.2K |
2023 Q4
4 quarters
|
|
13548
PUT
Zegna
ZGN
$3.37B
| $10.7K | ﹤0.01% |
1,300
-100
| -7% | -$817 |
2023 Q4
4 quarters
|
|
13549
PUT
IZEA Worldwide
IZEA
$42.3M
| $10.7K | ﹤0.01% |
+3,900
| New | +$10.5K |
2024 Q4
0 quarters
|
|
13550
PUT
Nerdy
NRDY
$58.6M
| $10.7K | ﹤0.01% |
440
-1,187
| -73% | -$22.1K |
2022 Q4
8 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.